Recent advances in autoimmune pancreatitis: Type 1 and type 2

Postgraduate Medical Journal

Volumn 90, Issue 1059, 2014, Pages 18-25

  Kamisawa, Terumi ^a   Chari, Suresh T ^b   Lerch, Markus M ^c   Kim, Myung Hwan ^d   Gress, Thomas M ^e   Shimosegawa, Tooru ^f  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b MAYO CLINIC   (United States)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^d University of Ulsan College of Medicine   (South Korea)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; MAMMALIAN TARGET OF RAPAMYCIN; MERCAPTOPURINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ARTICLE; AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FIBROSIS; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HISTOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; INFLAMMATORY BOWEL DISEASE; OBSTRUCTIVE JAUNDICE; PANCREATITIS; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84890136813     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2012-304224rep     Document Type: Article

References (78)

1. Okazaki K, Kawa S, Kamisawa T, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009;38:849-66.
2. Kamisawa T, Takuma K, Egawa N, et al. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 2010;7:401-9.
3. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-8.
4. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009;58:1504-7.
5. Hart PA, Kamisawa T, Brugger WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre international analysis. Gut 2013;62:1771-6.
6. Kamisawa T, Notohara K, Shimosegawa T. Two clinicopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology 2010;139:22-5.
7. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009;58:1680-9.
8. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010;139:140-8.
9. Chari ST, Kloppel G, Zhang L, et al. Histologic and clinical subtypes of autoimmune pancreatitis: The Honolulu Consensus Document. Pancreas 2010;39:549-54.
10. Sarles H, Sarles JC, Muratoren R, et al. Chronic inflammatory sclerosing of the pancreas-An autonomous pancreatic disease? Am J Dig Dis 1961;6:688-98.
11. Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387-95.
12. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
13. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society (2002). Suizo 2002;17:585-7. (in Japanese with English abstract)
14. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-4.
15. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration. Clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119-27.
16. Kamisawa T, Egawa N, Nakajima H, et al. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2004;39:1154-8.
17. Chari ST, Smyrk TC, Levy MJ, et al. Autoimmune pancreatitis: diagnosis using histology, imaging, serology, other organ involvement and response to steroids. Clin Gastroenterol Hepatol 2006;4:1010-16.
18. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revised. World J Gastroenterol 2006;12:2487-96.
19. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008;134:706-15.
20. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008;6:364-6.
21. Moon SH, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008;57:1704-12.
22. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009;10:1097-103.
23. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40:352-8.
24. Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013;62:1607-15.
25. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997;41:263-8.
26. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virch Arch 2004;445:552-63.
27. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012;64:3061-7.
28. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012;22:21-30.
29. Shimosegawa T; Working group members of the Japan Pancreas Society; Research Committee for Intractable Pancreatic Disease by the Ministry of Labor, Health and Welfare of Japan. The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic criteria (ICDC) for autoimmune pancreatitis. Pancreas 2012;41:1341-2.
30. Schneider A, Lohr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classification of the disease. J Gastroenterol 2007;42:101-19.
31. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009;104:2288-94.
32. Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas 2011;40:352-8.
33. Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007;4:314-23.
34. Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009;361:2135-42.
35. Löhr JM, Faissner R, Koczan D, et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling, and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol 2010;105:2060-71.
36. Okazaki K, Uchida K, Miyoshi H, et al. Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol 2011;41:126-38.
37. Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011;46:277-88.
38. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51.
39. Chang MC, Chang YT, Tien YW, et al. T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem 2007;53:1700-5.
40. Umemura T, Ota M, Hamano H, et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 2008;103:588-94.
41. Schwaiger T, van den Brandt C, Fitzner B, et al. Autoimmune pancreatitis in MRL/ Mp mice is a T-cell mediated disease responsive to cyclosporine A and rapamycin treatment. Gut Published Online First: 5 Apr 2013. doi:10.1136/gutjnl-2012-303635
42. Umemura T, Katsuyama Y, Hamano H, et al. Association analysis of Toll-like receptor 4 polymorphisms with autoimmune pancreatitis. Hum Immunol 2009;70:742-6.
43. Guenther A, Aghdassi A, Muddana V, et al. Toll-like receptor 4 polymorphisms in German and US patients are associated with occurrence or severity of acute pancreatitis. Gut 2010;59:1154-5.
44. Kawa S, Ota M, Yoshizawa K, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002;122:1264-9.
45. Park DH, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQβ1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008;134:440-6.
46. Seleznik GM, Reding T, Romrig F, et al. Lymphotoxin β receptor signalling promotes development of autoimmune pancreatitis. Gastroenterology 2012;143:1361-74.
47. Sendler M, Dummer A, Weiss FU, et al. Tumor necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice. Gut 2013;62:430-9.
48. Krüger B, Lerch MM, Tessenow W. Direct detection of premature protease activation in living pancreatic acinar cells. Lab Invest 1998;78:763-4.
49. Halangk W, Krüger B, Ruthenbürger M, et al. Trypsin activity is not involved in premature, intrapancreatic trypsinogen activation. Am J Physiol Gastrointest Liver Physiol 2002;282:G367-74.
50. Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001;1:405-15.
51. Zenker M, Mayerle J, Lerch MM, et al. Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nat Genet 2005;37:1345-50.
52. Mayerle J, Dummer A, Sendler M, et al. Differential roles of inflammatory cells in pancreatitis. J Gastroenterol Hepatol 2012;27(Suppl 2):47-51.
53. Kanno H, Nose M, Itoh J, et al. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clinical and experimental immunology 1992;89:68-73.
54. Qu WM, Miyazaki T, Terada M, et al. A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid. Clinical and experimental immunology 2002;129:27-34.
55. Ota M, Ito T, Umemura T, et al. Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population. Dis markers 2011;31:223-9.
56. Lerch MM, Mayerle J. The benefits of diagnostic ERCP in autoimmune pancreatitis. Gut 2011;60:565-6.
57. Song TJ, Kim JH, Kim MH, et al. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis. J Gastroenterol Hepatol 2012;27:700-8.
58. Kamisawa T, Kim MH, Liao WC, et al. Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria. Pancreas 2011;40:200-5.
59. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004;99:932-7.
60. Kim JH, Kim MH, Byun JH, et al. Diagnostic Strategy for Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Is an Endoscopic Retrograde Pancreatography Essential? Pancreas 2012;41:639-47.
61. Sugumar A, Chari ST. Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol 2009;7:S59-62.
62. Kamisawa T, Imai M, Chen YO, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 2008;37:e62-7.
63. Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 2011;60:666-70.
64. Moon SH, Kim MH. The role of endoscopy in the diagnosis of autoimmune pancreatitis. Gastrointest Endosc 2012;76:645-56.
65. Kamisawa T, Shimosegawa T. Pancreas: Histological diagnostic criteria for autoimmune pancreatitis. Nat Rev Gastroenterol Hepatol 2012;9:8-10.
66. Detlefsen S, Drewes A, Vyberg M, et al. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch 2009;454:531-9.
67. Mizuno N, Bhatia V, Hosoda W, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009;44:742-50.
68. Brais RJ, Davies SE, O'Donovan M, et al. Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials. Pancreatology 2012;12:8-15.
69. Fusaroli P, Saftoiu A, Mancino MG, et al. Techniques of image enhancement in EUS (with videos). Gastrointest Endosc 2011;74:645-55.
70. Hocke M, Ignee A, Dietrich CF. Contrast-enhanced endoscopic ultrasound in the diagnosis of autoimmune pancreatitis. Endoscopy 2011;43:163-5.
71. Dietrich CF, Hirche TO, Ott M, et al. Real-time tissue elastography in the diagnosis of autoimmune pancreatitis. Endoscopy 2009;41:718-20.
72. Kamisawa T, Takuma K, Anjiki H, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 2010;105:1870-5.
73. Kamisawa T, Takuma K, Anjiki H, et al. FGD-PET/CT findings of autoimmune pancreatitis. Hepatogastroenterology 2010;57:447-50.
74. Endo T, Takizawa S, Tanaka S, et al. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 2009;58:732-7.
75. Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45:471-7.
76. Kim MH, Moon SH. The need for a consensus on the definition of remission of autoimmune pancreatitis after steroid treatment. Gut 2010;59:1730.
77. Iida H, Kubota K, Yoneda M, et al. A Case of Autoimmune pancreatitis developed pancreatic tail cancer. Pancreas 2009;38:483-4.
78. Maire F, Le Baleur Y, Rebours V, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 2011;106:151-6.